Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Perrigo (NY:PRGO)

27.22 +0.08 (+0.29%)
Official Closing Price Updated: 7:00 PM EDT, Jul 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 665,552
Open 27.31
Bid (Size) 27.22 (2)
Ask (Size) 28.23 (1)
Prev. Close 27.14
Today's Range 26.97 - 27.43
52wk Range 23.14 - 30.93
Shares Outstanding 137,200,000
Dividend Yield 4.26%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
These 3 Dividend Stocks Combine Strong Yields With Upside
These three high-yield dividend stocks are well-positioned to deliver a strong return, making them attractive to both income and growth-oriented investors 
Via MarketBeat
Topics World Trade
Earnings Scheduled For May 7, 2025
Via Benzinga

Performance

YTD
+4.7%
+4.7%
1 Month
+4.0%
+4.0%
3 Month
+5.2%
+5.2%
6 Month
+8.7%
+8.7%
1 Year
+2.8%
+2.8%

More News

Read More
Trump Tariffs Could Have 'Significant Impact' On Perrigo Earnings, Says JP Morgan
Via Benzinga
Topics Government World Trade
Nasdaq, S&P 500 Head for Worst Weekly Losses Since September
Via Talk Markets
Topics Economy Stocks Stocks / Equities
Perrigo Outlines 2025 Growth Plans, Projects Sales Boost And Margin Expansion By 2027
Via Benzinga
Earnings Scheduled For February 27, 2025
Via Benzinga
Earnings Scheduled For February 27, 2024
Via Benzinga
Perrigo Supports Customers through Tough Times, Supporting Shareholders through Changes
Via Benzinga
These stocks are gapping in today's session
Via Chartmill
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Via Benzinga
JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability
Via Benzinga
PRGO Stock Earnings: Perrigo Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Abbott Labs (ABT) Stock Falls on Baby Formula Ruling. What to Know.
Via InvestorPlace
AbbVie Appeals To Supreme Court Over Attorney-Client Privilege In 'Long-Standing' AndroGel Case
Via Benzinga
$20M Bet On This Energy Stock? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
PRGO Stock Earnings: Perrigo Beats EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Disney To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
CVS Health's Zero-Cost Coverage Paves Way For OTC Birth Control Access
Via Benzinga
Hidden Gems: 3 Market Underdogs to Buy at Rock-Bottom Prices
Via InvestorPlace
Around $2M Bet On Tile Shop Holdings? Check Out These 4 Stocks Insiders Are Buying
Via Benzinga
Stocks Mixed As Consumer Confidence Falls
Via Talk Markets
OTC Medicine Player Perrigo Outlines Three-Year Cost Saving Plan, Posts Mixed Q4 Earnings
Via Benzinga
Insiders bet big on these turnaround stocks
Via MarketBeat
Topics Economy Initial Public Offering
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga

Frequently Asked Questions

Is Perrigo publicly traded?
Yes, Perrigo is publicly traded.
What exchange does Perrigo trade on?
Perrigo trades on the New York Stock Exchange
What is the ticker symbol for Perrigo?
The ticker symbol for Perrigo is PRGO on the New York Stock Exchange
What is the current price of Perrigo?
The current price of Perrigo is 27.22
When was Perrigo last traded?
The last trade of Perrigo was at 07/09/25 07:00 PM ET
What is the market capitalization of Perrigo?
The market capitalization of Perrigo is 3.73B
How many shares of Perrigo are outstanding?
Perrigo has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.